GENEVA, May 6 -- NURA BIO, INC. (171 Oyster Point Blvd., Suite 401South San Francisco, California 94080) filed a patent application (PCT/US2024/052422) for "COVALENT SARM1 INHIBITORS" on Oct 22, 2024. With publication no. WO/2025/090514, the details related to the patent application was published on May 01, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MEDINA, Julio C. (171 Oyster Point Blvd., Suite 401South San Francisco, California 94080), SINGHA ROY, Moumita (171 Oyster Point Blvd., Suite 401South San Francisco, California 94080), LI, Guo (171 Oyster Point Blvd., Suite 401South San Fran...